[go: up one dir, main page]

GB202105509D0 - Viral infections - Google Patents

Viral infections

Info

Publication number
GB202105509D0
GB202105509D0 GBGB2105509.0A GB202105509A GB202105509D0 GB 202105509 D0 GB202105509 D0 GB 202105509D0 GB 202105509 A GB202105509 A GB 202105509A GB 202105509 D0 GB202105509 D0 GB 202105509D0
Authority
GB
United Kingdom
Prior art keywords
viral infections
infections
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2105509.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phoxgen Ltd
Original Assignee
Phoxgen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phoxgen Ltd filed Critical Phoxgen Ltd
Priority to GBGB2105509.0A priority Critical patent/GB202105509D0/en
Publication of GB202105509D0 publication Critical patent/GB202105509D0/en
Priority to UY0001039313A priority patent/UY39313A/en
Priority to US18/013,856 priority patent/US20230301948A1/en
Priority to CN202180060987.4A priority patent/CN116648242A/en
Priority to PCT/EP2021/068425 priority patent/WO2022003200A1/en
Priority to EP21742078.5A priority patent/EP4175503A1/en
Priority to MX2023000242A priority patent/MX2023000242A/en
Priority to JP2023523677A priority patent/JP2023531568A/en
Priority to IL299572A priority patent/IL299572A/en
Priority to TW110124423A priority patent/TW202207952A/en
Priority to AU2021298896A priority patent/AU2021298896A1/en
Priority to BR112022026880A priority patent/BR112022026880A2/en
Priority to TW110144033A priority patent/TW202237165A/en
Priority to MX2023006136A priority patent/MX2023006136A/en
Priority to EP21815214.8A priority patent/EP4250991A1/en
Priority to JP2023532329A priority patent/JP2023550838A/en
Priority to IL303225A priority patent/IL303225A/en
Priority to AU2021388910A priority patent/AU2021388910A1/en
Priority to CN202180091736.2A priority patent/CN117580477A/en
Priority to US18/265,981 priority patent/US20240050512A1/en
Priority to PCT/EP2021/083029 priority patent/WO2022112430A1/en
Ceased legal-status Critical Current

Links

GBGB2105509.0A 2020-07-03 2021-04-18 Viral infections Ceased GB202105509D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GBGB2105509.0A GB202105509D0 (en) 2021-04-18 2021-04-18 Viral infections
BR112022026880A BR112022026880A2 (en) 2020-07-03 2021-07-02 REDUCTION OF VIRAL INFECTIONS
AU2021298896A AU2021298896A1 (en) 2020-07-03 2021-07-02 Reduction of viral infections
US18/013,856 US20230301948A1 (en) 2020-07-03 2021-07-02 Reduction of viral infections
CN202180060987.4A CN116648242A (en) 2020-07-03 2021-07-02 reduce viral infection
PCT/EP2021/068425 WO2022003200A1 (en) 2020-07-03 2021-07-02 Reduction of viral infections
EP21742078.5A EP4175503A1 (en) 2020-07-03 2021-07-02 Reduction of viral infections
MX2023000242A MX2023000242A (en) 2020-07-03 2021-07-02 Reduction of viral infections.
JP2023523677A JP2023531568A (en) 2020-07-03 2021-07-02 Reduction of virus infection
IL299572A IL299572A (en) 2020-07-03 2021-07-02 Reduction in viral infections
TW110124423A TW202207952A (en) 2020-07-03 2021-07-02 Viral infections
UY0001039313A UY39313A (en) 2020-07-03 2021-07-02 BUFFERING COMPOSITIONS FOR THE TREATMENT OF AIRBORNE VIRAL INFECTIONS
PCT/EP2021/083029 WO2022112430A1 (en) 2020-11-25 2021-11-25 Reduction of viral infections
TW110144033A TW202237165A (en) 2020-11-25 2021-11-25 Novel compositions and methods of treatment
MX2023006136A MX2023006136A (en) 2020-11-25 2021-11-25 Reduction of viral infections.
EP21815214.8A EP4250991A1 (en) 2020-11-25 2021-11-25 Reduction of viral infections
JP2023532329A JP2023550838A (en) 2020-11-25 2021-11-25 Reduction of virus infection
IL303225A IL303225A (en) 2020-11-25 2021-11-25 Reducing viral infections
AU2021388910A AU2021388910A1 (en) 2020-11-25 2021-11-25 Reduction of viral infections
CN202180091736.2A CN117580477A (en) 2020-11-25 2021-11-25 Reducing viral infection
US18/265,981 US20240050512A1 (en) 2020-11-25 2021-11-25 Reduction of viral infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2105509.0A GB202105509D0 (en) 2021-04-18 2021-04-18 Viral infections

Publications (1)

Publication Number Publication Date
GB202105509D0 true GB202105509D0 (en) 2021-06-02

Family

ID=76377712

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2105509.0A Ceased GB202105509D0 (en) 2020-07-03 2021-04-18 Viral infections

Country Status (2)

Country Link
CN (2) CN116648242A (en)
GB (1) GB202105509D0 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5711918A (en) * 1980-06-24 1982-01-21 Tokai Daigaku Remedy for herpes virus infection in human bodies
US5863563A (en) * 1994-10-20 1999-01-26 Alphagene Inc. Treatment of pulmonary conditions associated with insufficient secretion of surfactant
US20020006961A1 (en) * 1999-05-14 2002-01-17 Katz Stanley E. Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
CA2591702A1 (en) * 2004-12-16 2006-07-27 Cavit Sciences, Inc. Methods and compositions for treatment of viral infections
EP2280690A2 (en) * 2008-04-18 2011-02-09 Nanobio Corporation Methods for treating herpes virus infections
WO2017212422A1 (en) * 2016-06-08 2017-12-14 Novartis Consumer Health Sa Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions

Also Published As

Publication number Publication date
CN117580477A (en) 2024-02-20
CN116648242A (en) 2023-08-25

Similar Documents

Publication Publication Date Title
IL263972A (en) Dihydropyranopyrimidines for the treatment of viral infections
PL4157272T3 (en) Remdesivir for the treatment of viral infections
CA191793S (en) Hand vacuum
GB202102049D0 (en) Viruses
ZA202202370B (en) Compositions and methods for treating viral infections
DK3829116T3 (en) Adaptiv routing
EP3945975A4 (en) VACUUM
EP4000487A4 (en) VACUUM
GB201803197D0 (en) Viral treatment
GB201814625D0 (en) Packet processing
GB2590785B (en) Loudspeakers
EP4070705A4 (en) VACUUM
GB201902453D0 (en) Destination prediciton
GB202105509D0 (en) Viral infections
GB202020320D0 (en) Viral infections
GB202018571D0 (en) Viral infections
GB202018446D0 (en) Viral infections
GB202013976D0 (en) Viral infections
GB202010271D0 (en) Viral infections
IL288713A (en) Methods to treat viral infections
EP3650015A4 (en) Combined medicinal preparation for treating viral infections
CA213682S (en) Hand vacuum
GB202411176D0 (en) Viral infections
GB202211075D0 (en) Virus
GB202211076D0 (en) Virus

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)